Study to Analyze the Aerobic Performance Efficacy of Chronic Intake With a β-alanine Supplement in Recreational Cyclists (B-AC3)

Universidad Católica San Antonio de Murcia

Status: Completed

Conditions: Beta Alanine Supplementation

Treatments: Dietary Supplement: Control product; Dietary Supplement: Beta Alanine high dose; Dietary Supplement: Beta Alanine low dose

Study type: Interventional

Funder types: Other

Identifiers

NCT06167395

UCAMCFE-00031

Details and patient eligibility

About

Randomized, controlled, double-blind, double-blind clinical trial, with three parallel arms depending on the product consumed (experimental product dose 1 and dose 2 and placebo product) and single-center, to measure the efficacy of a sustained release beta alanine on the aerobic performance efficacy in recreational cyclist

Full description

Subjects meeting the selection criteria will be randomly assigned to each of the study groups (investigational product dose 1 or dose 2, or placebo, depending on the group to which they have been assigned).

The product to be consumed is beta alanine. Participants will consume the product for 30 days. They will have to take 4 intakes every three hours, being the first intake two hours after waking up.

The study subjects will have to make 2 visits to the laboratory. At the first and last visit, their aerobic performance will be evaluated by an incremental test to exhaustion with gas analysis.

Enrollment: 75 patients

Sex: Male

Ages: 18 to 60 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Male cyclists with more than two years of cycling experience.
• Perform tests without fatigue.
• Road bike training at least twice a week.

Exclusion criteria

• Participants with chronic illness.
• Have a long-term injury that prevents you from training in the previous month.
• Inability to understand informed consent.
• Have consumed beta alanine in the three years prior to the start of the study.
• Consumption of other supplements that may alter performance.

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

75 participants in 3 patient groups, including a placebo group

Beta Alanine high dose

Experimental group

Description:

Consumption for 30 days.

Treatment:

Dietary Supplement: Beta Alanine high dose

Beta Alanine low dose

Experimental group

Description:

Consumption for 30 days.

Treatment:

Dietary Supplement: Beta Alanine low dose

Control group

Placebo Comparator group

Description:

Consumption for 30 days.

Treatment:

Dietary Supplement: Control product